Interestingly, in this study of participants with diabetes and overweight or obesity, diabetes treatment was associated with Aβ42, Aβ40, Aβ42/Aβ40, and NfL, while BMI was associated only with GFAP. Here, GFAP is linked to obesity due to melanocortin 4 receptor deficiency.